Fintel reports that on October 18, 2024, Argus Research downgraded their outlook for Elevance Health (NYSE:ELV) from Buy to ...

On Friday, the S&P 500 rose 23.20 points, or 0.40%, to 5,864.67 points, while the Nasdaq Composite advanced 115.94 points, or 0.63%, to 18,489.55. The Dow Jones Industrial Average gained 36.86 points, ...

Wells Fargo analyst Steve Baxter has maintained their bullish stance on ELV stock, giving a Buy rating yesterday. Steve Baxter has given his ...

Elevance Health's dependence on government plans is considerable, but even with very conservative growth expectations, ELV ...

Many Republicans and some Democrats have supported expanding what the plans cover more broadly, though other Democrats have cautioned the changes could undermine the Affordable Care Act by offering ...

Donald Berwick, who ran Medicare during the Obama administration, says Medicare Advantage plans run by private insurers need a lot more regulation. He suggests a two-pronged system fix that would take ...

Q3 2024 Earnings Call Transcript October 17, 2024 Elevance Health Inc. misses on earnings expectations. Reported EPS is $8.37 ...

Elevance Health (NYSE: ELV) 公布了2024年第三季度财报，调整后每股摊薄收益为8.37美元，由于Medicaid业务医疗成本上升，未能达到预期。该公司已将全年调整后每股收益展望下调至约33美元，原因是Medicaid板块持续面临挑战。 Elevance Health由于Medicaid业务医疗成本上升和州政府合作伙伴费率调整滞后，面临短期挑战。尽管存在这些不利因素，公司 ...

UnitedHealth and Elevance saw double-digit decreases in their stocks this week after they reported worse-than-expected ...

Asian shares are higher after China's central bank released plans for supporting stock markets through share repurchases.

Despite strong revenue growth, Elevance Health Inc (ELV) faces hurdles with elevated Medicaid costs impacting earnings ...

U.S. stocks drifted around their record heights following the latest signals that the U.S. economy continues to hum ...